First‐in‐human safety, tolerability, pharmacokinetics and pilot food‐effect study of the candidate antimalarial compound MMV367

Documenti analoghi

• Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin
  di: Andrea Kuemmerle, et al.
  Pubblicazione: (2024)
• Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
  di: Clifford G. Banda, et al.
  Pubblicazione: (2024)
• The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat
  di: Chandrali S. Bhattacharya, et al.
  Pubblicazione: (2024)
• “Mas deixemos de lado o Senhor Bataille!”
  di: Madeline Chalon
  Pubblicazione: (2013)
• Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments
  di: Junjie Ding, et al.
  Pubblicazione: (2024)